

VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products Among its major competitors, VIVUS is ranked in 6th place for NPS while Biogen is 1st, and Arena Pharmaceuticals is 2nd.Their current market cap is $8.34M